Novartis International AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world.
Our purpose is to reimagine medicine to improve and extend people’s lives. Novartis uses innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time, and ideas in our company.
Novartis is structured to deliver innovative products, exploit a global scale, and respond to new opportunities and risks.
Our Innovative Medicines business, made up of two separate commercial organizations, Innovative Medicines International and Innovative Medicines in the US, commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
Advanced Accelerator Applications is a Novartis company focused only on radioligand therapy and precision imaging.
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on diseases of the eye.